Epstein Secrets

ing instructions use a HIGH COST method for relieving assets from your position J.P.Morgan Page 18 of 23 SB1062192-F1 1662 EFTA01663534 ef I GHISLAINE MA XWE1.1.-HY ACCT. For the Period 12/1/I Ito 12/31/11 Portfolio Activity Detail INFLOWS & OUTFLOWS Settle Date Type Description Quantity Per U

Y HEALTH TENDER OFFER ON CUSIP: 12543DAF7 (ID: 1259913-J2-1) 1,000.000 0.00 J.P.Morgan SB1062192-F1 Page 20 of 23 1664 EFTA01663536 it I GIUSLAINE MAXWELL NY ACCT. For the Period 12/1/1 Ito 12/31/11 Settle Date Type Description Quantity Selection Method Cost Interest Purchased 12/6 Accrued IM Pa

ccruals 19,645.63 19.645 63 Market Value with Accruals $1.002,757.71 $1.002.757.71 J.P.Morgan Page 2 of 19 SB1062192-F1 1598 EFTA01663470 GHISLAINE MAXWELL-HY ACCT. For the Period 10/1/11 w 10/31/11 Account Summary CONTINUED Tax Summary Current Period Value Year•to•Date Value Current P

matters addressed herein or for the purpose of avoiding U.S. tax•related penalties. Remarks NONE Account Details Authorized Signers: GHISLAINE MAXWELL J.P.Morgan Page 3 of 23 SB1062192-F1 1647 EFTA01663519 GHISLAINE MAXWELL•HY ACCT. For the Period 1211/I I to 12/31/11 Account Summary Asse

68 JPMorgan Chase Bank. N.A. 270 Park Avenue. GHISLAINE MAXWELL-HY ACCT. For the Period 10/I/II to 10/31/11 10

B /B2 CONSTELLATION BRANDS INC 110.00 15,000.00 16,500.00 16,50000 1,087.50 5.10% 71/4% MAY 15 2017 138.94 DTD 11/15/2007 21036P-AF-5 BB. /BA2 INGLES MARKETS INC 10825 10,000.00 10,825.00 10.775.00 50.00 887.50 7.00% 8 7/8% MAY 15 2017 113.40 DTD 05/12/2009 457030-AG-9 BB- /61 RRI

8% AUG 15 2021 DID 15,000.000 0.042 628.13 08/10/2009 (ID: 46284P-AM-6) J.P.Morgan Page 17 of 19 SB1062192-F1 1711 EFTA01663583 CHISLAINF: MAXWELLMY ACCT. For the Period 2/1/12 to 2/29/12 Type Quantity Per Unit Amount Amount Settle Date Method Description Cost Income 2/15 Corporate In

e 1,012,229.53 Total $1,012,229.53 J.P. Morgan To-Date Value Unrealized Gain/Loss $13.603.59 Page 3 of 19 SB1062192-F1 1697 EFTA01663569 GHISLA1NE MAXWELLAIY ACCT. For the Period 2/1/12 to 2/29/12 Cash & Fixed Income Summary Asset Categories Beginning Market Value Ending Market Value Change In Va

S 7 3/4% JUL 1 2017 129.16 DTD 6/22/2007 832248-AO-1 BB- /B2 J.P.Morgan Page 8 of 19 SB1062192-F1 1702 EFTA01663574 af' ef or 6111SIAINE MAXWELL-HY ACCT. For the Period 2/1/12 to 2/29/12 Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Income Yield Original Co

% SR NOTES 7 3/8% APR 01 2020 307.29 OTD 03/19/2010 912909-AF-5 BB /81 J.P.Morgan Page 12 of 19 SB1062192-F1 1706 EFTA01663578 1 at Aide, GHISLAINE A NAV F: L I.• ACCT. For the Period 2/1/12 to 2/29/12 Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Income Yield

NSTELLATION BRANDS INC 112.88 15,000.00 16,931.25 16,500.00 431.25 1,087.50 4.45% 7 1/4% MAY 15 2017 320.20 DTD 11/15/2007 21036P-AF-5 BB+ /BA2 INGLES MARKETS INC 109.75 10,000.00 10,975.00 10.775 00 200.00 887.50 6.63% 8 7/8% MAY 15 2017 26131 DTD 05/12/2009 457030-AG-9 8B- /81 RR

GHISLAINE MAXWELL-HY ACCT. For the Period 2/1/12 to 2/29/12 Pric

GHISLAINE MAXWELL-HY ACCT. For the Period 2/1/12 to 2/29/12 Pric

GHISLAINE MAXWELL-HY ACCT. For the Period 2/1/12 to 2/29/

NSTELLATION BRANDS INC 112.88 15.000.00 18,931.25 18,500.00 431.25 1,037.50 4.45% 7 1/4% MAY 15 2017 320.20 OTD 11/15/2007 21036P-AF-5 BB+ /BA2 INGLES MARKETS INC 109.75 10,000.00 10,975.00 10,775.00 200.00 887.50 8.63% 87/8% MAY 15 2017 281.31 DTD 05/12/2009 457030-AG-9 88-/81 RRI